Patient Perspectives and Understanding of MRI-directed Prostate Cancer Diagnosis

Affiliations

¹ UCL Division of Surgery and Interventional Science, University College London, London, United Kingdom; Department of Urology, University College London Hospitals NHS Foundation Trust, London, United Kingdom; Department of Urology, The Whittington Hospital, Whittington Health NHS Trust, London, United Kingdom. Electronic address: joseph.norris@ucl.ac.uk.
² Department of Pathology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
³ Department of Urology, The Whittington Hospital, Whittington Health NHS Trust, London, United Kingdom.
⁴ Department of Radiology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
⁵ Public & Patient Representative, Nottingham, United Kingdom.
⁶ UCL Division of Surgery and Interventional Science, University College London, London, United Kingdom.
⁷ School of Healthcare Sciences, Cardiff University, Wales, United Kingdom.
⁸ UCL Division of Surgery and Interventional Science, University College London, London, United Kingdom; Department of Urology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.

Comment

Joseph M Norris et al. Urology. 2021 Jul.

. 2021 Jul:153:6-7.

doi: 10.1016/j.urology.2021.03.031. Epub 2021 Apr 3.

¹ UCL Division of Surgery and Interventional Science, University College London, London, United Kingdom; Department of Urology, University College London Hospitals NHS Foundation Trust, London, United Kingdom; Department of Urology, The Whittington Hospital, Whittington Health NHS Trust, London, United Kingdom. Electronic address: joseph.norris@ucl.ac.uk.
² Department of Pathology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
³ Department of Urology, The Whittington Hospital, Whittington Health NHS Trust, London, United Kingdom.
⁴ Department of Radiology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
⁵ Public & Patient Representative, Nottingham, United Kingdom.
⁶ UCL Division of Surgery and Interventional Science, University College London, London, United Kingdom.
⁷ School of Healthcare Sciences, Cardiff University, Wales, United Kingdom.
⁸ UCL Division of Surgery and Interventional Science, University College London, London, United Kingdom; Department of Urology, University College London Hospitals NHS Foundation Trust, London, United Kingdom.

No abstract available

Comment on

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham AP, Oldroyd R, Parker C, Emberton M; PROMIS study group. Ahmed HU, et al. Lancet. 2017 Feb 25;389(10071):815-822. doi: 10.1016/S0140-6736(16)32401-1. Epub 2017 Jan 20. Lancet. 2017. PMID: 28110982